Doxycycline Post-Exposure Prophylaxis (Doxy PEP) for STI Prevention
Doxycycline taken right after sex is used as post-exposure prophylaxis (doxy PEP) to prevent bacterial sexually transmitted infections, particularly in high-risk populations such as men who have sex with men (MSM) and transgender women (TGW) who have had a bacterial STI in the past 12 months. 1
Recommended Population and Eligibility
CDC specifically recommends doxy PEP for:
Not currently recommended for:
- Cisgender women
- Cisgender heterosexual men
- Transgender men
- Other queer and nonbinary persons 1
Dosage and Administration
- 200 mg doxycycline as a single dose
- Take as soon as possible after sexual exposure
- Must be taken within 72 hours of condomless sex
- Maximum of 200 mg per 24-hour period 1, 2
- Take with food or milk and a full glass of water
- Remain upright for at least 1 hour after taking to prevent esophageal irritation 1
Efficacy
- Reduces syphilis and chlamydia infections by >70%
- Reduces gonococcal infections by approximately 50% 1, 3
- In the DoxyPEP trial, STI incidence was reduced by:
- 66% in MSM taking HIV PrEP (relative risk 0.34)
- 62% in MSM living with HIV (relative risk 0.38) 4
Clinical Implementation
Initial Visit
Screen for STIs at anatomic sites of exposure:
- Nucleic acid amplification test for gonorrhea and chlamydia
- Serologic testing for syphilis
- HIV testing for those not known to be HIV-positive 1
Provide counseling on:
- Potential side effects: photosensitivity, esophagitis, GI intolerance
- Antimicrobial resistance concerns
- Taking with food and plenty of fluid
- Not lying down for 1 hour after taking 1
Review drug interactions:
- Separate doxycycline by at least 2 hours from:
- Dairy products
- Antacids
- Supplements containing calcium, iron, magnesium, or sodium bicarbonate 1
- Separate doxycycline by at least 2 hours from:
Follow-up Visits
- Screen for STIs every 3-6 months
- Assess for side effects
- Re-evaluate need for continued doxy PEP
- Provide risk reduction counseling and condoms 1, 2
Important Considerations and Caveats
- Doxy PEP is distinct from pre-exposure prophylaxis (PrEP), which involves taking medication before exposure 1
- Should be implemented as part of a comprehensive sexual health approach 1
- Not effective for cisgender women - a randomized trial showed no significant reduction in STIs (relative risk 0.88) 5
- Concerns about antimicrobial resistance development - tetracycline-resistant gonorrhea was detected in some participants in clinical trials 4
- The Australian consensus recommends considering doxy PEP primarily for syphilis prevention in high-risk MSM 6
- Adherence may affect effectiveness - in the trial involving cisgender women, doxycycline was detected in only 29% of hair samples 5
Doxy PEP represents a novel approach to STI prevention that has shown significant efficacy in specific populations, but should be used selectively rather than as a population-level intervention due to resistance concerns and varying effectiveness across different groups.